4-[(4-Methoxyphenyl)methyl]-3-{1-[2-(3-methylphenoxy)acetyl]piperidin-4-yl}-4,5-dihydro-1H-1,2,4-triazol-5-one

Catalog No. :
ACVOQX593
CAS No. :
1775507-29-3
Molecular Formula :
C24H28N4O4
Molecular Weight :
436.51

IUPAC Name:4-(4-methoxybenzyl)-5-(1-(2-(m-tolyloxy)acetyl)piperidin-4-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one

4-[(4-Methoxyphenyl)methyl]-3-{1-[2-(3-methylphenoxy)acetyl]piperidin-4-yl}-4,5-dihydro-1H-1,2,4-triazol-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[(4-Methoxyphenyl)methyl]-3-{1-[2-(3-methylphenoxy)acetyl]piperidin-4-yl}-4,5-dihydro-1H-1,2,4-triazol-5-one
IUPAC Name4-(4-methoxybenzyl)-5-(1-(2-(m-tolyloxy)acetyl)piperidin-4-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one
MDL No.MFCD28805969
Molecular FormulaC24H28N4O4
Molecular Weight436.51
SMILESO=C1N(CC2=CC=C(OC)C=C2)C(C3CCN(C(COC4=CC=CC(C)=C4)=O)CC3)=NN1
InChI KeyHZMFIYXEAYGZNX-UHFFFAOYSA-N
Synonym4-[(4-methoxyphenyl)methyl]-3-{1-[2-(3-methylphenoxy)acetyl]piperidin-4-yl}-4,5-dihydro-1H-1,2,4-triazol-5-one;3H-1,2,4-Triazol-3-one, 2,4-dihydro-4-[(4-methoxyphenyl)methyl]-5-[1-[2-(3-methylphenoxy)acetyl]-4-piperidinyl]-
CAS No.1775507-29-3

Synthetic Route by SureRoute

1. ACVOQX593 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMVEG365 route compound structure diagram
    ACMVEG3651643-15-8 In Stock
  4. Then
  5. ACVOQX593 route product structure diagram
    ACVOQX5931775507-29-3
Inquiry

2. ACVOQX593 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVOQX593 route product structure diagram
    ACVOQX5931775507-29-3
Inquiry

Comments (0)